Final stage of the Spider validation! We are now assessing if the Spider can measure change over time. Hoping for as many volunteers as our last study (10,000!). So grateful for the HSD/hEDS community and their contribution to research 🦓 @jvsimmonds01
https://t.co/lxpgKpVDHW
Final stage of the Spider validation! We are now assessing if the Spider can measure change over time. Hoping for as many volunteers as our last study (10,000!). So grateful for the HSD/hEDS community and their contribution to research 🦓 @jvsimmonds01
https://t.co/lxpgKpVDHW
Parts 2 and 3 are now live! We’ve had an incredible response so far and would appreciate your ongoing support. Each survey asks about different symptoms you may experience.
Survey 2: https://t.co/p0wI55iM4Z
Survey 3: https://t.co/8d51RbmkyT
Very exciting - we are now testing ‘the Spider’ with adults with HSD/hEDS. The first stage of the study is now live for adults aged between 18 and 65 with and without HSD/hEDS. Please participate if able and share with others! https://t.co/V5NVZ9vd6c @jvsimmonds01@HMSACharity
The next step of the Adult Spider validation is now live! Part 3 is also live - if you are able to complete all 3 surveys we would be so grateful. Links below 🕷️
Part 1: https://t.co/cWh82FUocZ
Part 2: https://t.co/p0wI55iM4Z
Part 3: https://t.co/8d51RbmkyT
@jvsimmonds01
@Yrrepmot@jvsimmonds01@HMSACharity I absolutely agree - researching the cause and treatment options is certainly a high priority, but we do need tools measuring symptoms in order to better understand HSD/hEDS and assess outcomes of treatments to help us know what is successful
@Yrrepmot@jvsimmonds01@HMSACharity Before we can use the Spider in clinics we need to make sure it works correctly - which is why we are doing this study. We welcome any feedback and opinions. It is exciting to us, as we hope the Spider will make receiving individualised care much easier for people with HSD/hEDS
@Yrrepmot@jvsimmonds01@HMSACharity 2/3 A completed Spider questionnaire creates a diagram showing the impact of each individuals symptoms, which will help people communicate their symptoms more easily with healthcare teams to make sure that they receive care that focusses on what is impacting them the most
Huge congrats to @SueUnaWard for winning the outstanding platform award for her presentation on her scoping review of clinical characteristics of symptomatic hypermobility at #WorldPhysio2023. So well deserved for such excellent work 👏
Such an incredible experience - my first World Physio Congress! Delighted to have presented our Spider work, and to learn about all the latest Physiotherapy research. Such an inspiring weekend #WorldPhysio2023
This is a very important step in bringing the multisystem Spider measure into practice. We need young people 13-18yrs with and without hypermobility to complete this. Please share. @UCLchildhealth@TheEDSociety@HMSACharity
If you are planning to study on the UCL MSc paediatric or musculoskeletal physiotherapy or just want to hear their research sign up for this event. You will hear from fabulous alumni including @DrCMAlexander@christiniedougl@EllenEwer Elaine Chong and Becca Spear